Armenise D, Trapani G, Stasi F, Morlacchi F
Dipartimento Farmaco-chimico, Facoltà di Farmacia, Università degli Studi di Bari, Italy.
Arch Pharm (Weinheim). 1998 Feb;331(2):54-8. doi: 10.1002/(sici)1521-4184(199802)331:2<54::aid-ardp54>3.0.co;2-6.
Acid catalyzed cyclization reactions of both 3-alkyl- and 3-aryl-substituted N-(2,2-dialkoxyethyl)-3,4-dihydro-2H-1,4-benzothiazines (2) lead to 2,3-dihydro-pyrrolo[1,2,3-de]-1,4-benzothiazines (3). The pyrrolobenzothiazine structure was deduced on the basis of 2D 1H NMR-NOESY experiments and fully determined by X-ray data. Compounds 3a-c showed poor antibacterial activity. However, the 3-phenyl-N-(2,2-dimethoxyethyl)-3,4-dihydro-2H-1,4-benzothiazine (2b') showed antifungal activity against Aspergillus niger 16-fold greater than miconazole.
3-烷基和3-芳基取代的N-(2,2-二烷氧基乙基)-3,4-二氢-2H-1,4-苯并噻嗪(2)的酸催化环化反应均生成2,3-二氢-吡咯并[1,2,3-de]-1,4-苯并噻嗪(3)。吡咯并苯并噻嗪结构是根据二维1H NMR-NOESY实验推导出来的,并通过X射线数据完全确定。化合物3a-c显示出较弱的抗菌活性。然而,3-苯基-N-(2,2-二甲氧基乙基)-3,4-二氢-2H-1,4-苯并噻嗪(2b')对黑曲霉的抗真菌活性比咪康唑高16倍。